CDEK
← All organizations

Provepharm Sas

For profitContributed to NMEWebsite ↗

Also known as: Prove pharm | Provepharm Life Solutions | Provepharm SAS | PROVEPHARM SAS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jul 6, 2018

First marketed drug

Jun 1, 1998

First NDA

Apr 8, 2016

Last known activity

Jun 30, 2024

Timeline

1990s

  1. Jun 1, 1998

    Provepharm Sas— Founded

2010s

  1. Apr 8, 2016

    methylene blue— NDA Organization

  2. Jan 13, 2017

    piperacillin— Marketing Organization

2020s

  1. Jul 8, 2022

    indigotindisulfonate sodium— NDA Secondary Org

Drugs by trial phase (5 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (8)

Recent trials (7)

Details

Founded
Marseilles, FR Jun 1, 1998
First NDA
Apr 8, 2016
Last known activity
Jun 30, 2024

Designations held

  • Orphan drug
  • Accelerated approval